3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
6
Colorectal Neoplasms
2
Unresectable Locally Advanced or Metastatic Solid Tumors
1
HER2-positive Colorectal Cancer
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Gastrointestinal Stromal Tumors
1
Disease Progression
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Cholangiocarcinoma
1
Interventions
Leucovorin
3
Fluorouracil
3
Oxaliplatin
2
Folfox protocol
2
regorafenib
1
lenvatinib
1
donafenib
1
Surgical Procedures, Operative
1
Radiotherapy
1
Irinotecan
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Cirrhosis, Familial, with Pulmonary Hypertension
×
regorafenib
×
Clear all
NCT06946849
2025-04-27
SED-RO-ICC
Shanghai Zhongshan Hospital
Phase 2
Not yet recruiting
76 enrolled